Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.60% | 163.54 | 0.7% | $1305.95m | |
| LLY | Eli Lilly & Co. | -1.93% | 323.65 | 1.1% | $1056.02m | |
| ABBV | AbbVie, Inc. | -5.84% | 134.38 | 1.9% | $793.06m | |
| PFE | Pfizer Inc. | -0.75% | 43.83 | 0.9% | $778.51m | |
| BMY | Bristol-Myers Squibb Co. | -0.82% | 71.12 | 1.0% | $763.08m | |
| MRK | Merck & Co., Inc. | -0.52% | 86.19 | 0.7% | $687.90m | |
| AZN | AstraZeneca Plc | -0.13% | 54.84 | 1.0% | $411.81m | |
| NVS | Novartis AG | -0.73% | 76.01 | 0.2% | $216.26m | |
| GSK | GSK Plc | 0.31% | 29.45 | 0.3% | $214.53m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -4.41% | 200.16 | 8.2% | $210.64m | |
| GBT | Global Blood Therapeutics, Inc. | 0.04% | 68.10 | 5.4% | $190.73m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.21% | 151.22 | 0.0% | $178.64m | |
| IDXX | IDEXX Laboratories, Inc. | -1.81% | 325.80 | 3.9% | $175.84m | |
| HZNP | Horizon Therapeutics Plc | -1.28% | 61.89 | 5.4% | $160.55m | |
| NVO | Novo Nordisk A/S | -0.74% | 99.65 | 0.1% | $140.44m |
Company Profile
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.